A study just underway at UW Medicine is evaluating whether a lab-formulated monoclonal antibody could curb the over-amplified inflammatory response that some patients experience with COVID-19 pneumonia. The researchers are evaluating the drug's
Recent findings in mice suggest a new approach to test in protecting people with diabetes from their higher risk of advanced blood vessel disease, which sets the stage for early heart attacks and strokes.
A new study by University of Washington researchers reveals how cells keep inflammation in check by secreting protein antagonists that bind to and block inflammatory signals from white cells.
A new Center for Innate Immunity and Immune Disease at UW Medicine seeks to become a world leader in finding therapies to regulate the body’s defense system and fend off a wide variety of diseases.
A team of researchers including Jeff McLean of the University of Washington has published dramatic new findings on bacteria that are detectable but have evaded cultivation in the lab.
